Menard Financial Group LLC Zoetis Inc. Transaction History

Menard Financial Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$155.97 - $200.09 $939,875 - $1.21 Million	-6,026 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$181.39 - $234.03 $179,031 - $230,987	987 Added 19.59%	6,026 $1.14 Million
Q4 2021 Feb 14, 2022	BUY	$193.69 - $247.03 $249,085 - $317,680	1,286 Added 34.27%	5,039 $1.23 Million
Q3 2021 Nov 15, 2021	BUY	$189.29 - $209.69 $79,691 - $88,279	421 Added 12.64%	3,753 $729,000
Q2 2021 Aug 11, 2021	BUY	$155.9 - $187.99 $31,024 - $37,410	199 Added 6.35%	3,332 $621,000
Q1 2021 May 17, 2021	SELL	$144.0 - $169.39 $61,776 - $72,668	-429 Reduced 12.04%	3,133 $493,000
Q4 2020 Feb 09, 2021	BUY	$157.07 - $174.35 $40,681 - $45,156	259 Added 7.84%	3,562 $590,000
Q3 2020 Nov 12, 2020	BUY	$137.1 - $165.37 $35,234 - $42,500	257 Added 8.44%	3,303 $546,000
Q2 2020 Aug 13, 2020	BUY	$111.92 - $142.53 $340,908 - $434,146	3,046 New	3,046 $417,000
Q1 2020 May 15, 2020	SELL	$92.66 - $144.94 $490,820 - $767,747	-5,297 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$116.25 - $133.25 $615,776 - $705,825	5,297 New	5,297 $701,000

1,921

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $84.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Menard Financial Group LLC with notifications on news.